AJANTA PHARMA
|
The Current P/S Ratio of AJANTA PHARMA is 7.23.
| Share Price | ₹3,341.4 | Oct 13,2026 |
| Market Cap | ₹41,766.9 Cr | |
| Sales-TTM | ₹5,776.2 Cr | TTM-Consolidated Results |
| Price/Sales | 7.23x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of AJANTA PHARMA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹41,766.9 Cr] as on Oct 13,2026
(/) Sales [ ₹5,776.2 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 7.23x ]
Thus, for AJANTA PHARMA , the investors are currently willing to pay '7.23 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of AJANTA PHARMA !
The chart below summarizes the trend in P/S Ratio of AJANTA PHARMA over the last five years.
Historical PS (Price/Sales) ratio chart of AJANTA PHARMA
PS Ratio Performance Analysis for AJANTA PHARMA
- AJANTA PHARMA 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 5.77x.
- AJANTA PHARMA 's operated at median p/e ratio of 6.42x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, AJANTA PHARMA 's p/e ratio peaked in Mar2025 at 7.04x.
- AJANTA PHARMA 's p/e ratio hit its five-year low in Mar2023 of 4.07x.
How does AJANTA PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| AJANTA PHARMA | 5,776.2 | 7.23 | 41,766.9 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 59,910.5 | 7.09 | 424,466.0 |
| DIVIS LABORATORIES LTD | 11,230.0 | 21.93 | 246,222.0 |
| TORRENT PHARMACEUTICALS LTD | 15,723.0 | 11.21 | 176,300.0 |
| CIPLA LTD | 28,324.4 | 3.79 | 107,447.0 |
| DR REDDYS LABORATORIES LTD | 33,227.9 | 3.11 | 103,471.0 |
| MANKIND PHARMA LTD | 14,737.9 | 6.64 | 97,850.4 |
| LUPIN LTD | 29,966.6 | 2.99 | 89,628.8 |
| ZYDUS LIFESCIENCES LTD | 28,591.7 | 3.95 | 112,818.0 |
| AUROBINDO PHARMA LTD | 34,935.3 | 2.77 | 96,836.1 |
| LAURUS LABS LTD | 7,269.6 | 15.24 | 110,823.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs AJANTA PHARMA 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.77x |
| Max industry PS | 21.93x |
| Median industry PS | 6.64x |
| Average industry PS | 7.81x |
You may also like the below Video Courses